Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BJN
|
|||
| Former ID |
DNC014484
|
|||
| Drug Name |
(+/-)-threo-3',4'-Dichloromethylphenidate amide
|
|||
| Synonyms |
CHEMBL1253379; BDBM50327177; (+/-)-threo-3'',4''-Dichloromethylphenidate amide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H16Cl2N2O
|
|||
| Canonical SMILES |
C1CCNC(C1)C(C2=CC(=C(C=C2)Cl)Cl)C(=O)N
|
|||
| InChI |
1S/C13H16Cl2N2O/c14-9-5-4-8(7-10(9)15)12(13(16)18)11-3-1-2-6-17-11/h4-5,7,11-12,17H,1-3,6H2,(H2,16,18)/t11-,12-/m1/s1
|
|||
| InChIKey |
OUZYXOJONCTZTI-VXGBXAGGSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Dopaminergic synapse | |||
| Parkinson's disease | ||||
| Cocaine addiction | ||||
| Amphetamine addiction | ||||
| Alcoholism | ||||
| Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
| Parkinson disease | ||||
| Dopamine receptor mediated signaling pathway | ||||
| Pathway Interaction Database | Alpha-synuclein signaling | |||
| Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
| WikiPathways | Monoamine Transport | |||
| NRF2 pathway | ||||
| Dopaminergic Neurogenesis | ||||
| Parkinsons Disease Pathway | ||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
| Neurotransmitter Clearance In The Synaptic Cleft | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.